What is the latest import price of Ropilastin/Romilastin in 2025?
Romiplostim is a biological agent used to treat idiopathic thrombocytopenia (ITP). It stimulates megakaryocytes in the bone marrow to produce platelets, thereby effectively increasing the number of platelets in the patient's body. In clinical applications, roplastin is usually administered by subcutaneous injection. The initial recommended dose for adults is 1 mcg/kg body weight once weekly. During treatment, doctors will make dose adjustments based on the patient's platelet count to ensure reasonable platelet levels are maintained. In addition to dosage adjustments, the patient's overall health status, comorbidities, and use of other medications will also affect the efficacy and safety of Ropremilast.
While using loplastin, patients need to have regular blood tests to evaluate changes in platelets and monitor possible side effects. Common side effects include headache, fatigue, joint pain, etc. Most patients can tolerate these discomforts, but if serious adverse reactions occur, they should contact their doctor in time. In addition, the use of roplastin is not suitable for all patients, especially patients with a history of bone marrow suppression, active thrombosis, etc., and should be used with caution.
The original drug Ropremilast for injection has been launched in the domestic market and has been added to the medical insurance catalog. However, due to its recent launch, purchase channels are limited. In Hong Kong, the original research version sells for about more than 9,000 yuan a piece, while the Hong Kong version is slightly lower, about more than 8,000 yuan (exchange rate changes may cause price fluctuations). At the same time, the European version and the German version of the original drug Roplastin sold overseas cost approximately RMB 10,000 (affected by exchange rates). Despite the price difference, the ingredients of the drugs remain the same. At present, there is no presence of Roprostim in the overseas generic drug market.
Reference:https://en.wikipedia.org/wiki/Romiplostim
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)